Page last updated: 2024-12-05

calamenene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

calamenene: from the New Zealand Liverwort Lepidolaena hodgsoniae; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Lepidolaenagenus[no description available]Lepidolaenaceae[no description available]

Cross-References

ID SourceID
PubMed CID6429077
MeSH IDM0487754

Synonyms (29)

Synonym
naphthalene, 1,2,3,4-tetrahydro-1,6-dimethyl-4-(1-methylethyl)-, (1s-cis)-
cadina-1,3,5-triene
cis-calamenene
(z)-calamenene
(1s,4s)-1,6-dimethyl-4-propan-2-yl-1,2,3,4-tetrahydronaphthalene
calamenene
483-77-2
(1s-cis)-1,6-dimethyl-4-(1-methylethyl)-1,2,3,4-tetrahydronaphthalene
unii-r8o22wbf8l
r8o22wbf8l ,
PGTJIOWQJWHTJJ-STQMWFEESA-N
calamenene, (-)-
calamenene, cis-(-)-
(1s,4s)-1,2,3,4-tetrahydro-1,6-dimethyl-4-(1-methylethyl)naphthalene
1s-cis-calamenene
naphthalene, 1,6-dimethyl-4-(1-methylethyl)-1,2,3,4-tetrahydro-, (1s-z)-
(-)-cadina-1,3,5-triene
1,2,3,4-tetrahydro-1,6-dimethyl-4(1-methylethyl)-(1s-cis)-naphthalene
naphthalene, 1,2,3,4-tetrahydro-1,6-dimethyl-4- (1-methylethyl)-, (1s-cis)-
Q63398612
(+/-)-cadina-1,3,5-triene
calamenene, cis-(+/-)-
unii-5c6w67n6xm
72937-55-4
5C6W67N6XM ,
naphthalene, 1,2,3,4-tetrahydro-1,6-dimethyl-4-(1-methylethyl)-, (1r,4r)-rel-
DTXSID40880702
1-s-cis-calamenene
DTXSID501042907
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (42.86)29.6817
2010's6 (42.86)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]